Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.6M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
25M
-
Shares change
-
+92.1K
-
Total reported value, excl. options
-
$245M
-
Value change
-
+$902K
-
Number of buys
-
13
-
Number of sells
-
-9
-
Price
-
$9.79
Significant Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q1 2023
38 filings reported holding VIGL - Vigil Neuroscience, Inc. - Common Stock as of Q1 2023.
Vigil Neuroscience, Inc. - Common Stock (VIGL) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25M shares
of 46.6M outstanding shares and own 53.65% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (5.84M shares), Northpond Ventures, LLC (4.21M shares), Artal Group S.A. (2.24M shares), CITADEL ADVISORS LLC (2.16M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.05M shares), Deep Track Capital, LP (2.03M shares), BVF INC/IL (1.81M shares), VANGUARD GROUP INC (729K shares), Cormorant Asset Management, LP (617K shares), and Pivotal bioVenture Partners Investment Advisor LLC (561K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.